James T. Rosenbaum
   HOME
*





James T. Rosenbaum
James T. Rosenbaum (born September 29, 1949) is an American physician-scientist who is Senior Vice President for Research at Corvus Pharmaceuticals and Chief of Ophthalmology emeritus at the Legacy Devers Eye Institute, Portland, Oregon, where he held the Richard Chenoweth Chair. Previously, he was Chief of Arthritis and Rheumatic Diseases at the Oregon Health & Science University where he held the Edward E Rosenbaum Professorship in Inflammation Research. Rosenbaum was the only practicing rheumatologist/non-ophthalmologist in the world to serve as a chief of ophthalmology. He is recognized for his description of an animal model of uveitis (inflammation inside the eye) resulting from injection of bacterial endotoxin (Nature, 286:611, 1980) and for more than 600 scholarly publications, mostly related to the intersection between rheumatology and ophthalmology. He is a co-author of the book, ''"The Clinical Neurology of Rheumatic Diseases''". Education Rosenbaum is a National Merit Sch ...
[...More Info...]      
[...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  


Legacy Devers Eye Institute
The Legacy Devers Eye Institute in Portland, Oregon, is one of the few private, non-profit centers for ophthalmological care, research, and training in the United States. The institute is affiliated with Legacy Health, a network of seven hospitals in Portland and Southwest Washington. Legacy Devers includes the Thelma and Gilbert Schnitzer Comprehensive Glaucoma Center. Mission The institute offers fee-for-service and charitable eye care. Part of its mission is to provide universal eye care in the Portland, Oregon, area. The institute also trains post-graduate professionals and conducts research. Scientists from Devers have refined how to interpret visual field testing, a standard part of the assessment of glaucoma. They have also improved corneal transplantation through innovations in DLEK (deep lamellar endothelial keratoplasty) and DSEK (Descemet's stripping with endothelial keratoplasty). History and funding The Devers Eye Institute was founded in 1959 thanks to a million-dol ...
[...More Info...]      
[...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  



MORE